Sanna‐Kaisa Herukka

8.7k total citations · 1 hit paper
106 papers, 3.5k citations indexed

About

Sanna‐Kaisa Herukka is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Sanna‐Kaisa Herukka has authored 106 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 38 papers in Psychiatry and Mental health and 35 papers in Neurology. Recurrent topics in Sanna‐Kaisa Herukka's work include Alzheimer's disease research and treatments (53 papers), Dementia and Cognitive Impairment Research (37 papers) and Cerebrospinal fluid and hydrocephalus (16 papers). Sanna‐Kaisa Herukka is often cited by papers focused on Alzheimer's disease research and treatments (53 papers), Dementia and Cognitive Impairment Research (37 papers) and Cerebrospinal fluid and hydrocephalus (16 papers). Sanna‐Kaisa Herukka collaborates with scholars based in Finland, Sweden and United States. Sanna‐Kaisa Herukka's co-authors include Hilkka Soininen, Tuula Pirttilä, Irina Alafuzoff, Päivi Hartikainen, Tero Tapiola, Laura Parkkinen, Seppo Helisalmi, Merja Hallikainen, Anne M. Koivisto and Henrik Zetterberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Sanna‐Kaisa Herukka

104 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

2009 651 citations Sanna‐Kaisa Herukka, Päivi Hartikainen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanna‐Kaisa Herukka Finland	34	1.9k	1.3k	891	889	636	106	3.5k
Seppo Helisalmi Finland	38	2.5k 1.3×	1.3k 1.0×	670 0.8×	1.2k 1.3×	736 1.2×	132	4.5k
Maria Bjerke Belgium	32	2.2k 1.1×	1.8k 1.3×	572 0.6×	1.2k 1.3×	872 1.4×	79	4.2k
Daniel Alcolea Spain	35	1.5k 0.8×	906 0.7×	845 0.9×	889 1.0×	594 0.9×	112	3.1k
Enikò Kövari Switzerland	38	1.6k 0.8×	880 0.7×	982 1.1×	899 1.0×	996 1.6×	84	4.1k
Annika Öhrfelt Sweden	28	2.5k 1.3×	1.3k 1.0×	1.7k 1.9×	1.3k 1.4×	1.1k 1.7×	40	4.7k
M Orantes Germany	4	1.9k 1.0×	1.0k 0.8×	697 0.8×	580 0.7×	673 1.1×	4	2.7k
Richard J. Perrin United States	29	1.7k 0.9×	697 0.5×	1.4k 1.6×	922 1.0×	694 1.1×	81	3.7k
Joshua A. Sonnen United States	34	1.5k 0.8×	1.4k 1.0×	920 1.0×	672 0.8×	849 1.3×	81	3.8k
Luisa Benussi Italy	39	2.3k 1.2×	726 0.5×	1.3k 1.5×	1.7k 2.0×	953 1.5×	138	5.0k
Roberta Ghidoni Italy	43	2.6k 1.3×	867 0.6×	1.4k 1.6×	1.9k 2.1×	995 1.6×	158	5.6k

Countries citing papers authored by Sanna‐Kaisa Herukka

Since Specialization

Citations

This map shows the geographic impact of Sanna‐Kaisa Herukka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanna‐Kaisa Herukka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanna‐Kaisa Herukka more than expected).

Fields of papers citing papers by Sanna‐Kaisa Herukka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanna‐Kaisa Herukka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanna‐Kaisa Herukka. The network helps show where Sanna‐Kaisa Herukka may publish in the future.

Co-authorship network of co-authors of Sanna‐Kaisa Herukka

This figure shows the co-authorship network connecting the top 25 collaborators of Sanna‐Kaisa Herukka. A scholar is included among the top collaborators of Sanna‐Kaisa Herukka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanna‐Kaisa Herukka. Sanna‐Kaisa Herukka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagman, Sanna, et al.. (2024). The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis. Multiple Sclerosis and Related Disorders. 85. 105517–105517. 7 indexed citations

Benussi, Alberto, Valentina Cantoni, Mario Grassi, et al.. (2023). Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase. Brain stimulation. 16(6). 1666–1676. 6 indexed citations

Kokkola, Tarja, Anne M. Koivisto, Merja Kokki, et al.. (2023). Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer s Disease. 94(2). 727–736. 5 indexed citations

Huber, Nadine, Sanna‐Kaisa Herukka, Annakaisa Haapasalo, et al.. (2023). Rare PMP22 variants in mild to severe neuropathy uncorrelated to plasma GDF15 or neurofilament light. Neurogenetics. 24(4). 291–301. 3 indexed citations

Jääskeläinen, Olli, Shalini Das Gupta, Pedro Andrade, et al.. (2022). Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI. International Journal of Molecular Sciences. 23(23). 15208–15208. 7 indexed citations

Molchanova, Svetlana M., Nadine Huber, Sanna‐Kaisa Herukka, et al.. (2022). Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons. Frontiers in Cell and Developmental Biology. 9. 820105–820105. 33 indexed citations

Rebelos, Eleni, Eero Rissanen, Marco Bucci, et al.. (2022). Circulating neurofilament is linked with morbid obesity, renal function, and brain density. Scientific Reports. 12(1). 7841–7841. 40 indexed citations

Hartikainen, Sirpa, et al.. (2020). Parkinsonin taudin lääkkeiden erityiskorvausoikeuden saajien määrän muutos vuosina 1996-2015. UEF eRepo (University of Eastern Finland). 1 indexed citations

Jeppsson, Anna, Carsten Wikkelsø, Kaj Blennow, et al.. (2019). CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. Journal of Neurology Neurosurgery & Psychiatry. 90(10). 1117–1123. 67 indexed citations

10.

Jääskeläinen, Olli, Eino Solje, Anette Hall, et al.. (2019). Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients. Journal of Alzheimer s Disease. 72(1). 127–137. 13 indexed citations

11.

Katisko, Kasper, Eino Solje, Anne M. Koivisto, et al.. (2018). Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers. Journal of Neuroimmunology. 321. 29–35. 18 indexed citations

12.

Tuusa, Jussi, Wataru Nishie, Nina Kokkonen, et al.. (2018). BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer’s Disease than in Bullous Pemphigoid. Journal of Investigative Dermatology. 139(2). 293–299. 20 indexed citations

13.

Katisko, Kasper, Nina Kokkonen, Johanna Krüger, et al.. (2018). The Association Between Frontotemporal Lobar Degeneration and Bullous Pemphigoid. Journal of Alzheimer s Disease. 66(2). 743–750. 5 indexed citations

14.

Kokkonen, Nina, Sanna‐Kaisa Herukka, Laura Huilaja, et al.. (2016). Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease. Journal of Investigative Dermatology. 137(1). 71–76. 59 indexed citations

15.

Zwan, Marissa D., Juha O. Rinne, Steen Gregers Hasselbalch, et al.. (2015). Use of amyloid-PET to determine cutpoints for CSF markers. Neurology. 86(1). 50–58. 47 indexed citations

16.

Zetterberg, Henrik, Michael P. Lunn, & Sanna‐Kaisa Herukka. (2012). Clinical Use of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease. Biomarkers in Medicine. 6(4). 371–376. 4 indexed citations

17.

Hallikainen, Ilona, Anne M. Koivisto, Teemu Paajanen, et al.. (2012). Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer’s Disease: Kuopio ALSOVA Study. Dementia and Geriatric Cognitive Disorders Extra. 2(1). 209–218. 14 indexed citations

18.

Seppälä, Toni T., Sanna‐Kaisa Herukka, Tuomo Hänninen, et al.. (2010). Plasma A 42 and A 40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. Journal of Neurology Neurosurgery & Psychiatry. 81(10). 1123–1127. 79 indexed citations

19.

Gils, Mark van, Juha Koikkalainen, Jussi Mattila, et al.. (2010). Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer's disease. PubMed. 27. 2886–2889. 10 indexed citations

20.

Herukka, Sanna‐Kaisa, Merja Hallikainen, Hilkka Soininen, & Tuula Pirttilä. (2005). CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. Neurology. 64(7). 1294–1297. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact